Complete heart block: Determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy

被引:78
|
作者
Chang, SM [1 ]
Nagueh, SF [1 ]
Spencer, WH [1 ]
Lakkis, NM [1 ]
机构
[1] Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA
关键词
D O I
10.1016/S0735-1097(03)00623-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The purpose of this paper is to examine the incidence and determinants of permanent complete heart block (CHB) after nonsurgical septal reduction therapy (NSRT), and to evaluate the clinical impact of permanent pacemaker (PPM) placement. BACKGROUND Nonsurgical septal reduction therapy with ethanol improves the clinical and hemodynamic parameters in patients with symptomatic hypertrophic obstructive cardiomyopathy. Complete heart block is a common complication after NSRT. METHODS The database of 261 consecutive patients who underwent NSRT at Baylor College of Medicine was reviewed. Clinical variables that were considered as possible determinants for CHB after NSRT were: age, gender, New York Heart Association (NYHA) functional class, left ventricular outflow tract (LVOT) gradient at rest or with provocation, septal thickness, and baseline exercise duration. For electrocardiographic (ECG) variables, the presence of first-degree atrioventricular (AV) block, bifascicular block, left bundle branch block, atrial fibrillation, and left ventricular hypertrophy were analyzed. In addition, the volume of ethanol injected, the method of administration of ethanol (i.e., bolus vs. slow injection [over 30 to 60 s]), number of septal arteries occluded, use of myocardial echocardiography, and infarct size as determined by peak creatine kinase level. RESULTS Of 261 consecutive patients, 37 had PPM or automatic implantable cardiac defibrillator placed before NSRT. Of the remaining 224 patients, 31 (14%) developed CHB after the procedure. Multivariate logistic regression analysis showed that female gender (odds ratio [OR] 4.3; p = 0.02), bolus injection of ethanol (OR 51; p = 0.004), injecting more than one septal artery (OR 4.6; p = 0.016), the presence of left bundle branch block (OR 39; p = 0.002), and first-degree AV block (OR 14; p = 0.001) on the baseline ECG are independent predictors of CHB after NSRT. Patients requiring PPM placement had a similar improvement in their NYHA functional class, septal thickness reduction, LVOT gradient reduction, and improvement of exercise capacity when compared with patients who did not require pacing. CONCLUSIONS Multiple demographic, electrocardiographic, and technical factors seem to increase the risk of CHB after NSRT. Patients with CHB after NSRT derive similar clinical and hemodynamic benefit to patients who did not require permanent pacing. (C) 2003 by the American College of Cardiology Foundation.
引用
收藏
页码:296 / 300
页数:5
相关论文
共 50 条
  • [31] Acute predictors of subacute complete heart block after alcohol septal ablation for obstructive hypertrophic cardiomyopathy
    Chen, AA
    Palacios, IF
    Mela, T
    Yoerger, DM
    Picard, MH
    Vlahakes, G
    Lowry, PA
    Fifer, MA
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (02): : 264 - 269
  • [32] Complete heart block complicating alcohol septal ablation for hypertrophic cardiomyopathy
    Cheng, TO
    TEXAS HEART INSTITUTE JOURNAL, 1999, 26 (01) : 100 - 100
  • [33] Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction
    Desai, Milind Y.
    Owens, Anjali
    Wolski, Kathy
    Geske, Jeffrey B.
    Saberi, Sara
    Wang, Andrew
    Sherrid, Mark
    Cremer, Paul C.
    Lakdawala, Neal K.
    Tower-Rader, Albree
    Fermin, David
    Naidu, Srihari S.
    Smedira, Nicholas G.
    Schaff, Hartzell
    McErlean, Ellen
    Sewell, Christina
    Zhong, Yue
    Wyrwich, Kathleen W.
    Lampl, Kathy L.
    Sehnert, Amy J.
    Nissen, Steven E.
    Spertus, John A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (11) : 1041 - 1045
  • [34] Decreased expression of turner necrosis factor-α and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy
    Nagueh, SF
    Stetson, SJ
    Lakkis, NM
    Killip, D
    Perez-Verdia, A
    Entman, ML
    Spencer, WH
    Torre-Amione, G
    CIRCULATION, 2001, 103 (14) : 1844 - 1850
  • [35] Relationship of number of septal branches injected and creatinine kinase area under the curve in nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
    Aguilar, OM
    Meyer, D
    Fromm, RE
    Spencer, WH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 88A - 88A
  • [36] Nonsurgical septal reduction for symptomatic hypertrophic obstructive cardiomyopathy: The Baylor experience (1996-1999)
    Lakkis, N
    Nagueh, S
    Killip, D
    Torre, G
    Roberts, R
    Spencer, W
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2000, 13 (03) : 157 - 159
  • [37] Avoiding papillary muscle infarction with myocardial contrast echocardiographic guidance of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
    Nagueh, SF
    Lakkis, NM
    Middleton, KJ
    Franklin, J
    Spencer, WH
    CIRCULATION, 2004, 109 (05) : E27 - E28
  • [38] Incidence and Predictors of Late Complete Heart Block After Alcohol Septal Ablation Treatment of Hypertrophic Obstructive Cardiomyopathy
    Schuller, Joseph L.
    Zipse, Matthew M.
    Krantz, Mori J.
    Blaker, Brian
    Salcedo, Ernesto
    Groves, Bertron M.
    Messenger, John C.
    Beaty, Brenda
    Sauer, William H.
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2015, 28 (01) : 90 - 97
  • [39] There's More to the ECG: Predictors of Complete Heart Block after Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
    Heizer, Justin
    Divoky, Laura
    Rier, Jeremy
    Wahlquist, Amy
    Waring, Ashley
    Shaji, Shawn
    Litwin, Sheldon
    Gold, Michael
    Fernandes, Valerian
    Nielsen, Christopher
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B255 - B255
  • [40] Complications of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy with Focus on Complete Heart Block: A European Multicenter Study
    Veselka, Josef
    Lawrenz, Thorsten
    Stellbrink, Christoph
    Zemanek, David
    Branny, Marian
    Januska, Jaroslav
    Groch, Ladislav
    Dimitrow, Pawel
    Krejci, Jan
    Dabrowski, Maciej
    Mizera, Stanislav
    Kuhn, Horst
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B222 - B222